Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pennant Group ( (PNTG) ) has issued an update.
On October 1, 2025, The Pennant Group, Inc. completed the acquisition of certain home health, hospice, and personal care operations from UnitedHealth Group and Amedisys, Inc. for $146.5 million. This strategic acquisition, part of an antitrust settlement, expands Pennant’s presence into Tennessee, Georgia, and Alabama, marking a significant growth opportunity in the Southeast U.S. The transition is supported by a services agreement with UnitedHealth, and Pennant aims to leverage its operational excellence to integrate these new locations into its portfolio.
The most recent analyst rating on (PNTG) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Pennant Group stock, see the PNTG Stock Forecast page.
Spark’s Take on PNTG Stock
According to Spark, TipRanks’ AI Analyst, PNTG is a Outperform.
Pennant Group’s strong financial performance and positive earnings call sentiment are the most significant factors driving the score. While technical indicators show mixed signals, the company’s growth prospects and improved guidance provide a cautiously optimistic outlook. Valuation concerns and regulatory challenges are notable risks.
To see Spark’s full report on PNTG stock, click here.
More about Pennant Group
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located across several states in the United States. Each business operates independently with its own management, employees, and assets.
Average Trading Volume: 343,824
Technical Sentiment Signal: Sell
Current Market Cap: $877.9M
See more insights into PNTG stock on TipRanks’ Stock Analysis page.